冠心病危险指数对老年2型糖尿病患者颈动脉内膜增厚的风险评估

李诗薇; 于卫华; 陈德宇; 闫亭; 郑俊俊; 冯欢

doi:10.16766/j.cnki.issn.1674-4152.001853

冠心病危险指数对老年2型糖尿病患者颈动脉内膜增厚的风险评估

doi: 10.16766/j.cnki.issn.1674-4152.001853

1.
安徽医科大学第三附属医院合肥市第一人民医院护理部，安徽合肥 230061
2.
阜阳师范大学生物与食品工程学院，安徽阜阳 236000

基金项目:

国家自然科学基金项目 81771567

详细信息

通讯作者:
于卫华, E-mail: ywh-zr@tom.com

中图分类号: R587.1 R543.4
计量
- 文章访问数: 126
- HTML全文浏览量: 145
- PDF下载量: 2
- 被引次数: 0
出版历程
- 收稿日期: 2020-09-04
- 网络出版日期: 2022-02-16

Risk assessment of carotid intimal thickening in elderly patients with type 2 diabetes by coronary risk index: Inverted U curve

1.
Department of Nursing, the Third Affiliated Hospital of Anhui Medical University ( Hefei First People's Hospital) ，Hefei，Anhui 230061 ,China

摘要

摘要: 目的探讨冠心病危险指数(coronary risk index，CRI)对老年2型糖尿病(T2DM)患者发生颈动脉硬化疾病(CAD)的预测价值，为临床筛查CAD风险提供参考。方法选取2019年9—12月期间于合肥市第一人民医院及合肥市滨湖医院就诊的老年T2DM患者156例，以颈动脉内膜增厚和斑块形成作为分组依据将患者分为非颈动脉硬化组(55例)、颈动脉内膜增厚组(52例)和颈动脉斑块形成组(49例)，记录各组临床资料。使用SPSS 25.0统计学软件对数据进行分析。结果 Spearman相关性分析显示：冠心病危险指数与老年T2DM患者颈动脉内膜厚度呈正相关(r=0.158, P=0.049)。以CRI取值的四分位数作为临界值，将冠心病危险指数分为Q1~Q4四个区间，与颈动脉内膜厚度做logistic回归分析，结果显示：在Q1~Q3区间段，随着CRI升高，患者发生颈动脉内膜增厚的风险升高(OR值分别为1.000、1.677、5.333)，在Q4段，CRI升高对患者发生颈动脉内膜增厚的风险性略有降低(OR=2.970)；CRI升高对老年2型糖尿病患者颈动脉内膜增厚的风险预测具有倒U型关系。结论当患者CRI在3.59~4.14范围内，医护人员应观察患者是否存在微血管病变的临床征象；若CRI长期处于过高水平(CRI≥4.15)，应警惕发生隐匿性血管微病变。临床中可将总胆固醇与高密度脂蛋白胆固醇比值纳入老年T2DM患者CAD筛查中，综合评判患者发生CAD的风险。
- 冠心病危险指数 /
- 老年人 /
- 2型糖尿病 /
- 颈动脉内膜厚度 /
- 风险评估
Abstract: Objective To explore the predictive value of coronary risk index (CRI) for carotid atherosclerosis (CAD) in elderly patients with type 2 diabetes mellitus (T2DM) and provide references for clinical screening of risk for CAD. Methods A total of 156 elderly patients with T2DM who were treated in two third-class hospitals in Hefei from September 2019 to December 2019 were selected. On the basis of carotid artery intimal thickening and plaque formation, the patients were divided into non-carotid arteriosclerosis groups: Control group (55 cases), carotid artery intimal thickening group (52 cases) and carotid artery plaque formation group (49 cases). The clinical data of each group were recorded. Data were analysed using SPSS 25.0. Results Spearman correlation analysis revealed that the coronary heart disease risk index was positively correlated with carotid artery intima thickness in the elderly patients with T2DM (r=0.158, P=0.049). With the quartile of CRI as the critical value, the coronary heart disease risk index was divided into four intervals (Q1-Q4), and carotid artery intima thickness was analysed via logistic regression analysis. In the Q1-Q3 interval, as the risk of carotid artery intimal thickening increased as CRI increased (OR values for Q1, Q2 and Q3 were 1.000, 1.677 and 5.333, respectively). In the Q4 interval, increased CRI the risk of carotid artery intimal thickening slightly decreased as CRI increased (OR=2.970). The increase in ratio displayed an inverted U-shaped relationship with the risk of carotid artery intimal thickening in the elderly patients with T2DM. Conclusion When CRI ranges from 3.59 to 4.14, medical staff should carefully observe if patients are showing clinical signs of microvascular diseases; if the CRI is at an excessively high level for a long time (CRI ≥4.15), the staff should be alerted to the occurrence of occult microvascular diseases. Clinically, the Total Cholesterol/High-Density Lipoprotein Cholesterol (TC/HDL-C) ratio can be included in screening for CAD among elderly patients with T2DM to comprehensively evaluate the risk of CAD in these patients.
- Coronary risk index /
- Older Population /
- Type 2 diabetes /
- Carotid-intima thickness /
- Risk assessment

HTML全文

表 1 3组老年2型糖尿病患者临床资料比较[例(%)]

组别	例数	年龄(x ±s, 岁)	性别		职业状况		婚姻状况		BMI(x ±s)	病程(x ±s, 年)
组别	例数	年龄(x ±s, 岁)	男性	女性	无职业	退休	有伴侣	无伴侣	BMI(x ±s)	病程(x ±s, 年)
非颈动脉硬化组	55	68.75±7.95	19(34.55)	36(65.45)	48(87.27)	7(12.73)	51(92.73)	4(7.27)	23.12±2.76	9.58±6.75
颈动脉内膜增厚组	52	70.10±6.83	25(48.08)	27(51.92)	42(80.77)	10(19.23)	50(96.15)	2(3.85)	24.07±2.89	11.88±7.58
颈动脉斑块形成组	49	69.67±6.34	22(44.90)	27(55.10)	42(85.71)	7(14.23)	46(93.88)	3(6.12)	24.04±3.58	11.35±8.76
统计量		0.508^a	1.095^b		0.461^b		0.141^b		1.628^a	1.312^a
P值		0.603	0.337		0.631		0.868		0.200	0.272
注：^a为F值，^b为χ²值。

下载: 导出CSV

表 2 颈动脉内膜中层厚度与各指标的Spearman相关性分析

项目	r值	P值
年龄	0.094	0.245
病程	0.071	0.378
BMI	0.111	0.167
HbA1c	0.189	0.018
CRI	0.158	0.049
高密度脂蛋白胆固醇	0.046	0.565
低密度脂蛋白胆固醇	0.069	0.390

下载: 导出CSV

表 3 CRI与老年2型糖尿病患者发生CAD的logistic回归分析

区间	B	SE	Wald χ²	P值	OR值	95% CI
Q1(＜2.99)			11.705	0.008	1.000
Q2(2.99~3.58)	0.517	0.457	1.278	0.258	1.677	0.684~4.110
Q3(3.59~4.14)	1.674	0.527	10.106	0.001	5.333	1.900~14.970
Q4(≥4.15)	1.088	0.479	5.156	0.023	2.970	1.161~7.599

下载: 导出CSV

参考文献(24)

[1]	MURY P, FAES C, MILLON A, et al. Higher daily physical activity level is associated with lower rbc aggregation in carotid artery disease patients at high risk of stroke[J]. Front Physiol, 2017, 8(1): 1043.
[2]	KATAOKA Y, HOSODA K, MAKINO H, et al. The efficacy of glycemic control with continuous glucose monitoring on atheroma progression: rationale and design of the Observation of Coronary Atheroma Progression under Continuous Glucose Monitoring Guidance in Patients with Type 2 Diabetes Mellitus (OPTIMAL)[J]. Cardiovasc Diagn Ther, 2019, 9(5): 431-438. doi: 10.21037/cdt.2019.09.02
[3]	ARYA R, ESCALANTE A, FAROOK V S, et al. A genetic association study of carotid intima-media thickness (CIMT) and plaque in Mexican Americans and European Americans with rheumatoid arthritis[J]. Atherosclerosis, 2018, 271(1): 92-101. http://www.sciencedirect.com/science/article/pii/S0021915017314053
[4]	ARTHA IMJR, BHARGAH A, DHARMAWAN N K, et al. High level of individual lipid profile and lipid ratio as a predictive marker of poor glycemic control in type-2 diabetes mellitus[J]. Vasc Health Risk Manag, 2019, 15(1): 149-157. http://www.ncbi.nlm.nih.gov/pubmed/31239693
[5]	KAZEMI T, HAJIHOSSEINI M, MOOSSAVI M, et al. Cardiovascular risk factors and atherogenic indices in an Iranian population: Birjand East of Iran[J]. Clin Med Insights Cardiol, 2018, 12(1): 1-6. http://www.onacademic.com/detail/journal_1000040224737910_b021.html
[6]	中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2017年版)[J]. 中国实用内科杂志, 2018, 38(4): 292-344. https://www.cnki.com.cn/Article/CJFDTOTAL-SYNK201804009.htm
[7]	LU J, MA X, SHEN Y, et al. Time in range is associated with carotid intima-media thickness in type 2 diabetes[J]. Diabetes Technol Ther, 2019, 22(2): 72-78. http://www.researchgate.net/publication/335844100_Time_in_Range_Is_Associated_with_Carotid_Intima-Media_Thickness_in_Type_2_Diabetes
[8]	LIU X Z, FAN J, PAN S J. METS-IR, a novel simple insulin resistance indexes, is associated with hypertension in normal-weight Chinese adults[J]. J Clin Hypertens(Greenwich), 2019, 21(8): 1075-1081. doi: 10.1111/jch.13591
[9]	BORA K, PATHAK M S, BORAH P, et al. Association of the Apolipoprotein A-I gene polymorphisms with cardiovascular disease risk factors and atherogenic indices in patients from Assam[J]. Balkan J Med Genet, 2017, 20(1): 59-70. doi: 10.1515/bjmg-2017-0002
[10]	孙爱童, 刘炯鸥. 2型糖尿病患者下肢动脉血管回声跟踪技术检测指标与血脂及血糖的相关性[J]. 中华实用诊断与治疗杂志, 2017, 31(1): 62-64. https://www.cnki.com.cn/Article/CJFDTOTAL-HNZD201701019.htm
[11]	翟斐, 张新秀. 2型糖尿病患者血尿酸及同型半胱氨酸与颈动脉粥样硬化的关系[J]. 安徽医学, 2019, 40(11): 1249-1251. doi: 10.3969/j.issn.1000-0399.2019.11.019
[12]	石维, 陈雷, 卜瑞芳. 2型糖尿病患者合并动脉粥样硬化危险因素分析[J]. 中国医药, 2018, 13(6): 879-881. doi: 10.3760/j.issn.1673-4777.2018.06.020
[13]	LI H H, HUANG S, LIU X Z, et al. Applying the China-PAR risk algorithm to assess 10-year atherosclerotic cardiovascular disease risk in populations receiving routine physical examinations in Eastern China[J]. Biomed Environ Sci, 2019, 32(2): 87-95. http://www.cqvip.com/QK/84046X/201902/83878988504849574850484850.html
[14]	ZHANG M, ZHOU J, LIU Y, et al. Risk of type 2 diabetes mellitus associated with plasma lipid levels: the rural Chinese cohort study[J]. Diabetes Res Clin Pract, 2018, 135(1): 150-157. http://www.diabetesresearchclinicalpractice.com/article/S0168-8227(17)30617-4/pdf
[15]	梁美云, 冯正平. 2型糖尿病患者血钙水平与颈动脉内膜中层厚度的相关性研究[J]. 现代医药卫生, 2020, 36(17): 2726-2729. doi: 10.3969/j.issn.1009-5519.2020.17.020
[16]	YAN Y Z, FAN J N, LIU J M, et al. Use of blood lipid indicators as a screening tool of insulin resistance among individuals in low-income country sides of China: a multiethnic region study[J]. Mediators Inflamm, 2019(1): 3592620.
[17]	徐蓓峥, 俞建康, 黄新梅, 等. 社区中老年人群颈动脉粥样硬化与血浆致动脉粥样硬化指数的关系及其危险因素研究[J]. 中华全科医学, 2019, 17(1): 104-107. https://www.cnki.com.cn/Article/CJFDTOTAL-SYQY201901030.htm
[18]	于婷婷, 黄娜娜, 苏娇, 等. 中老年男性2型糖尿病患者下肢动脉粥样硬化斑块与骨密度的关系[J]. 中华实用诊断与治疗杂志, 2019, 33(2): 120-123. https://www.cnki.com.cn/Article/CJFDTOTAL-HNZD201902005.htm
[19]	LIU Y H, ZHU Y J, JIA W R, et al. Association between lipid profiles and presence of carotid plaque[J]. Sci Rep, 2019, 9(1): 18011. doi: 10.1038/s41598-019-54285-w
[20]	GAN L, YANG L, YAN G T. Predict value of adiponectin for coronary atherosclerosis plaques according to computed tomography angiography in an asymptomatic population[J]. Clin Imaging, 2018, 51(1): 174-179. http://www.onacademic.com/detail/journal_1000040419137410_860b.html
[21]	CAO X, WANG D, ZHOU J, et al. Comparison of lipoprotein derived indices for evaluating cardio-metabolic risk factors and subclinical organ damage in middle-aged Chinese adults[J]. Clin Chim Acta, 2017, 475(1): 22-27. http://www.ncbi.nlm.nih.gov/pubmed/28969987
[22]	SI X B, LIU W. Relationship between blood lipid and arterial stiffness in hypertension[J]. Clin Invest Med, 2019, 42(3): E47-E55. doi: 10.25011/cim.v42i3.33092
[23]	ELSHAZLY B M, NICHOLLS J S, NISSEN E S, et al. Implications of total to high-density lipoprotein cholesterol ratio discordance with alternative lipid parameters for coronary atheroma progression and cardiovascular events[J]. Am J Cardiol, 2016, 118(5): 647-655. doi: 10.1016/j.amjcard.2016.06.021
[24]	GHASEMZADEH Z, ABDI H, ASGARI S, et al. Divergent pathway of lipid profile components for cardiovascular disease and mortality events: results of over a decade follow-up among Iranian population[J]. Nutr Metab(Lond), 2016, 13(1): 43. doi: 10.1186/s12986-016-0102-1